PharmaTelevision - Francis Gurry, Director General of WIPO discusses the role of WIPO and the challenges they face

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Francis Gurry, Director General of WIPO discusses the role of WIPO and the challenges they face

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Francis Gurry, Director General of World Intellectual Property Organization

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Role and purpose of WIPO

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London, in 2011. On this show I have Francis Gurry, who is Director General of the WIPO a specialized agency of the United Nations, welcome.

Francis Gurry:

Thank you.

Fintan Walton:

So what is the sole purpose Francis of the WIPO?

Francis Gurry:

Well the sole purpose, the machine the centre matching is the promotion of the protection of intellectual property around the world and this of course to encourage innovation and cultural creativity. We have several sectors of activity one is that we make it easier for enterprises essentially to get intellectual property protection, we have systems that make it the way where you can file a single international application rather than a 180 under that 160,000 international patent applications are filed each year, 40,000 international trademark applications and a lesser number of international design applications. Then we have the development of the global legal framework, we enabling legal framework for intellectual property standard rules, we administrate over 20 treaties and we have a number of projects for the development of new international rules, then we coordinate global infrastructure database the technical IT standards and the last segment or sector of activity is enhancing the capacity of developing countries to participate in the system.

Fintan Walton:

Right, so in somewhere you just want the whole system are hubbed?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Francis Gurry

Director General

Francis Gurry is currently Director-General, World Intellectual Property Organization WIPO. Until recently he was Assistant Director-General and Legal Counsel of WIPO in Geneva where he was responsible for WIPO 's activities in the field of electronic commerce and the WIPO Arbitration and Mediation Center, as well as for international legal and constitutional questions and the Organization's relations with industry. Francis Gurry is a distinguished alumnus of the Melbourne Law School, holding an LLB and LLM from the University of Melbourne and a PhD from the University of Cambridge. He is a Vice President of the International Federation of Commercial Arbitration Institutions (IFCAI). Before joining WIPO in 1985, he practiced as a solicitor in Melbourne and Sydney. Francis Gurry is the author of a textbook on the law of trade secrets and confidential information, Breach of Confidence, (Oxford University Press 1984, and re-printed 1990), and co-author, with Frederick Abbott and Thomas Cottier, of The International Intellectual Property System: Commentary and Materials (Kluwer 1999).

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

WIPO

The World Intellectual Property Organization WIPO is a specialized agency of the United Nations. It is dedicated to developing a balanced and accessible international intellectual property (IP) system, which rewards creativity, stimulates innovation and contributes to economic development while safeguarding the public interest. WIPO was established by the WIPO Convention in 1967 with a mandate from its Member States to promote the protection of IP throughout the world through cooperation among states and in collaboration with other international organizations. Its headquarters are in Geneva, Switzerland. is an association of 32 national and regional societies, each composed of men and women who have an interest in the transfer of technology, or licensing of intellectual property rights - from technical knowhow and patented inventions to software, copyright and trademarks.